Cargando…
Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence
Hypertension is one of the most common morbidities in COVID-19. Previous studies demonstrated that hypertension increases composite poor outcomes in patients with COVID-19. Beta-blockers is widely used as one of the most common antihypertensive agents. Beta-blockers may hold potential benefits in CO...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550882/ https://www.ncbi.nlm.nih.gov/pubmed/34717930 http://dx.doi.org/10.1016/j.ihj.2021.10.011 |